
Fulvira 250mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Fulvestrant (250mg)
Overview Fulvira 250mg Injection
Estrogen suppression is achieved with the intramuscular injection of the 250mg Fulvira formulation. This medication is indicated for postmenopausal women with breast cancer. Its mechanism involves estrogen modulation to inhibit tumor cell proliferation. Administered intramuscularly under medical supervision, the dosage and frequency are determined by the treating physician based on individual needs and response. Treatment duration follows physician prescription. Common adverse events include injection site reactions, headache, nausea, vomiting, and allergic responses. Report any concerning side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your physician of any history of liver or kidney disease, bleeding disorders, anticoagulant use, or other medications being taken, as interactions are possible. Disclose current or planned pregnancy or breastfeeding.
Uses of Fulvira 250mg Injection
Malignant breast tumor
Major Benefits of Fulvira 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Fulvira 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulvira 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Fulvira 250mg Injection works:
Fulvira 250mg Injection inhibits estrogen's effects on breast cancer cells, potentially reducing or halting the proliferation of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of Fulvira 250mg Injection with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Fulvira 250mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential advantages outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Administration of Fulvira 250mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by Fulvira 250mg Injection.
KidneyCAUTION
Exercise caution when administering Fulvira 250mg Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Fulvira 250mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Fulvira 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulvira 250mg Injection :
Should you forget a scheduled dose of Fulvira 250mg Injection, seek advice from your physician.
Facts to Know About Fulvira 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Estrogen Derivatives |
| Developing Habits | No. |
| Type of Treatment | Cancer Treatments |
| Actions | Estrogen receptor blocker |
